Cargando…
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
BACKGROUND: Oncolytic viruses are currently experiencing accelerated development in several laboratories worldwide, with some forty-seven clinical trials currently recruiting. Many oncolytic viruses combine targeted cytotoxicity to cancer cells with a proinflammatory cell lysis. Due to their additio...
Autores principales: | Lei, Janet, Jacobus, Egon J., Taverner, William K., Fisher, Kerry D., Hemmi, Silvio, West, Katy, Slater, Lorna, Lilley, Fred, Brown, Alice, Champion, Brian, Duffy, Margaret R., Seymour, Len W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000980/ https://www.ncbi.nlm.nih.gov/pubmed/29898782 http://dx.doi.org/10.1186/s40425-018-0350-x |
Ejemplares similares
-
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation
por: Taverner, William K., et al.
Publicado: (2019) -
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion
por: Yousaf, Iris, et al.
Publicado: (2020) -
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
por: Illingworth, Sam, et al.
Publicado: (2017) -
Oncolytic Adenoviruses in Gastrointestinal Cancers
por: Yokoda, Raquel T., et al.
Publicado: (2018) -
Oncolytic Adenoviruses in Cancer Treatment
por: Alemany, Ramon
Publicado: (2014)